Search
Returning search results with filters:
Remove filter for
Last updated: 2020
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2020
- December 202010 results available
- November 20204 results available
- October 202012 results available
- September 20209 results available
- August 20202 results available
- July 20208 results available
- June 20209 results available
- May 202013 results available
- April 202010 results available
- March 202012 results available
- February 20203 results available
- January 20204 results available
Displaying 61 - 75 of 96 items.
Importation of Spanish-Labelled Salbutamol Aldo-Union inhalers due to Shortage of Canadian-Labelled Salbutamol
AlertHealth professional risk communication | 2020-05-19
Important Safety Information - Importation of Teva UK-labelled Salamol CFC-Free (Salbutamol Sulfate) Inhaler due to Shortage
AlertHealth professional risk communication | 2020-05-13
Unauthorized test kits claiming to diagnose or detect COVID-19 put your health at risk
AlertPublic advisory | 2020-05-07
Importation of US-Labelled Ketamine Hydrochloride for Injection due to Potential Shortage of Canadian-labelled Ketamine
AlertHealth professional risk communication | 2020-05-06
Clinical trial looking at the potential use of convalescent plasma to treat COVID-19
AlertPublic advisory | 2020-05-01
Axid (nizatidine) drug recalled due to presence of NDMA
AlertPublic advisory | 2020-05-01
Importation of US-Labelled Vecuronium Bromide for Injection due to Shortage of Neuromuscular Blocker Products
AlertHealth professional risk communication | 2020-04-29
Importation of US-Labelled QUELICIN (succinylcholine chloride injection) due to Shortage of Canadian-labelled QUELICIN
AlertHealth professional risk communication | 2020-04-29
Importation of US-Labelled Rocuronium Bromide Injection Due to Shortage of Canadian-labelled Rocuronium
AlertHealth professional risk communication | 2020-04-29
Importation of US-Labelled Pancuronium Bromide Injection Due to Shortage of Neuromuscular Blocker Products
AlertHealth professional risk communication | 2020-04-29
Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician.
AlertInformation update | 2020-04-25
Clinical management support: Known interference between Hemlibra® (emicizumab injection) and lab assays used to diagnose coagulopathy / DIC caused by COVID-19 infection
AlertHealth professional risk communication | 2020-04-17
Shortage of salbutamol inhalers in Canada
AlertPublic advisory | 2020-04-17